Therese M. Mulvey - Publications

Oncology Medical Homes: ASCO-Community Oncology Alliance Standards.

Journal: JCO oncology practice

Published: July 21, 2025

Morbidity, Mortality, and Improvement Rounds: Overlooked Risk in Cancer Care: Failure of Medical Reconciliation.

Journal: JCO oncology practice

Published: June 24, 2025

Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 19, 2025

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Journal: Oncology nursing forum

Published: July 01, 2024

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 27, 2024

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Journal: JCO oncology practice

Published: May 22, 2024

Supportive Care for Cancer Patients Via Telehealth: Breaking Bad News and Providing Palliative Care Virtually.

Journal: Cancer journal (Sudbury, Mass.)

Published: January 24, 2024

Physician Disruptive Behavior Compromising Safe Care Delivery.

Journal: JCO oncology practice

Published: January 04, 2024

Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Journal: JCO oncology practice

Published: November 03, 2023

Uncovering the Risks of Anticancer Therapy Through Incident Report Analysis Using a Newly Developed Medical Oncology Incident Taxonomy.

Journal: Journal of patient safety

Published: November 03, 2023

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 29, 2023

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Journal: NPJ breast cancer

Published: August 25, 2023

Filters

Oncology Medical Homes: ASCO-Community Oncology Alliance Standards.

Oncology Medical Homes: ASCO-Community Oncology Alliance Standards.

Morbidity, Mortality, and Improvement Rounds: Overlooked Risk in Cancer Care: Failure of Medical Reconciliation.

Morbidity, Mortality, and Improvement Rounds: Overlooked Risk in Cancer Care: Failure of Medical Reconciliation.

Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care.

Practical Guide to Clinical Trial Accessibility: Making Trial Participation a Standard of Care.

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.

Supportive Care for Cancer Patients Via Telehealth: Breaking Bad News and Providing Palliative Care Virtually.

Supportive Care for Cancer Patients Via Telehealth: Breaking Bad News and Providing Palliative Care Virtually.

Physician Disruptive Behavior Compromising Safe Care Delivery.

Physician Disruptive Behavior Compromising Safe Care Delivery.

Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.

Uncovering the Risks of Anticancer Therapy Through Incident Report Analysis Using a Newly Developed Medical Oncology Incident Taxonomy.

Uncovering the Risks of Anticancer Therapy Through Incident Report Analysis Using a Newly Developed Medical Oncology Incident Taxonomy.

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).